|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 979.60 INR | +0.68% |
|
-2.14% | +0.81% |
| 07-08 | INDIA STOCKS-Financials lead Indian equity benchmarks higher; tariff jitters cap gains | RE |
| 07-07 | Agenus Inc., Zydus Lifesciences Limited - M&A Call |
| Capitalization | 986B 11.49B 9.82B 9.15B 8.51B 15.73B 17.48B 110B 41.92B 462B 43.09B 42.2B 1,693B | P/E ratio 2025 |
19.7x | P/E ratio 2026 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 961B 11.2B 9.57B 8.92B 8.3B 15.33B 17.03B 107B 40.86B 450B 42B 41.13B 1,650B | EV / Sales 2025 |
3.85x | EV / Sales 2026 * | 3.71x |
| Free-Float |
24.85% | Yield 2025 |
1.24% | Yield 2026 * | 0.67% |
More valuation ratios
* Estimated data
More news
Last Transcript: Zydus Lifesciences Limited
More recommendations
More press releases
More news
| 1 day | +0.68% | ||
| 1 week | -2.14% | ||
| Current month | -1.05% | ||
| 1 month | +0.48% | ||
| 3 months | +12.75% | ||
| 6 months | +0.46% | ||
| Current year | +0.81% |
| 1 week | 965 |  | 1,001.3 |
| 1 month | 944 | | 1,015 |
| Current year | 795 | | 1,027.95 |
| 1 year | 795 | | 1,324.3 |
| 3 years | 340 | | 1,324.3 |
| 5 years | 319 | | 1,324.3 |
| 10 years | 202 | | 1,324.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2009-11-26 | |
| Director of Finance/CFO | - | - | |
| Compliance Officer | - | 2019-02-06 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 2007-03-31 | |
| Director/Board Member | 70 | 1997-07-31 | |
| Chairman | 72 | 2011-10-04 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.01% | 89 M€ | -0.33% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.68% | -2.14% | -16.64% | +165.94% | 11.49B | ||
| +0.57% | -0.26% | +6.00% | +94.38% | 46.76B | ||
| -0.22% | +2.32% | +27.30% | - | 24.13B | ||
| -0.84% | -1.43% | -6.75% | +34.37% | 23.97B | ||
| +0.49% | -1.87% | -1.79% | +55.77% | 13.98B | ||
| +14.55% | +19.16% | +57.88% | +465.49% | 7.17B | ||
| +1.28% | +2.06% | +37.85% | +99.30% | 7.1B | ||
| -0.51% | -5.10% | +61.33% | +75.27% | 7B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| Average | +1.60% | +1.27% | +20.65% | +141.50% | 15.41B | |
| Weighted average by Cap. | +0.82% | +0.50% | +11.83% | +106.36% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 230B 2.68B 2.29B 2.13B 1.98B 3.66B 4.07B 25.54B 9.77B 108B 10.04B 9.83B 394B | 250B 2.92B 2.49B 2.32B 2.16B 3.99B 4.44B 27.84B 10.65B 117B 10.94B 10.72B 430B |
| Net income | 46.43B 541M 463M 431M 401M 741M 823M 5.16B 1.97B 21.74B 2.03B 1.99B 79.73B | 45.37B 529M 452M 421M 392M 724M 804M 5.05B 1.93B 21.24B 1.98B 1.94B 77.92B |
| Net Debt | -24.94B -291M -249M -231M -215M -398M -442M -2.77B -1.06B -11.68B -1.09B -1.07B -42.83B | -56.37B -657M -562M -523M -487M -899M -999M -6.27B -2.4B -26.39B -2.46B -2.41B -96.81B |
More financial data
* Estimated data
Employees
26,921
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 979.60 ₹ | +0.68% | 921,032 |
| 25-07-10 | 972.95 ₹ | -0.56% | 721,738 |
| 25-07-09 | 978.45 ₹ | -0.48% | 906,874 |
| 25-07-08 | 983.20 ₹ | -1.56% | 1,014,905 |
| 25-07-07 | 998.80 ₹ | -0.22% | 567,413 |
Delayed Quote NSE India S.E., July 11, 2025 at 07:49 am
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
30
Last Close Price
979.60INR
Average target price
967.20INR
Spread / Average Target
-1.27%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZYDUSLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition